19
Jun
2024

Jiangsu Zhongbang Pharmaceutical Co., Ltd.

Exhibitor at CPHI & PMEC China 2024 stand E2A01, Pharma Ingredients
About Us

Jiangsu Zhongbang Pharmaceutical Co. Ltd. has been founded in 2001. As a high-tech enterprise, Zhongbang focuses on developing and producing pharmaceutical intermediates, APIs and finished products. The registered capital of Zhongbang is $1.26 billion and total area is 100,000 m2.

Zhongbang concentrates on the production technique of proton pump inhibitors “Prazole”, anti-hypertension “Sartan” and anticoagulants “Xaban” for more than 15 years. 

  • CN
  • 2015
    On CPHI since
  • 2
    Certificates
  • 250 - 499
    Employees
Company types
Manufacturer/Innovator
Primary activities
API Producer
Pharmaceutical Company (generic finished products)
Contact info
Event information
CPHI & PMEC China 2024
  • 19 - 21 June 2024
  • Shanghai New International Expo Center
  • Visit us at stand E2A01, Pharma Ingredients

Products Featured at CPHI & PMEC China 2024